The oncology segment held An important industry share in 2021. The phase is likely to develop at a greater CAGR in the forecast time period. Rise in the patient populace with differing kinds of cancer is anticipated to push the phase through the forecast period of time. Big pharmaceutical companies https://linktr.ee/salesforceeurope